We are a growth-oriented manufacturer of surface wellhead systems, or SWS, and oil country tubular goods, or OCTG products used in the oil and gas industry.
We are a growth-oriented manufacturer of surface wellhead systems, or SWS, and oil country tubular goods, or OCTG products used in the oil and gas industry.
We are a special purpose acquisition company incorporated on December 9, 2024 as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination in any business or industry but expect to target opportunities and companies that are in the digital asset and cryptocurrency sectors. While we may pursue an initial business combination in any industry, sector or geographic region, we intend to focus our search initially on identifying companies in the digital asset and cryptocurrency and adjacent sectors that power transformation and innovation. Our expertise lends itself well to pursuing platforms related to the digital asset, real estate, and related technology infrastructure sectors, but we are not required to complete our initial business combination with a business in these industries and, as a result, we may pursue a business combination outside of these industries. We expect to pursue global businesses but may also acquire a domestic company. We do not intend to acquire companies that are excessively leveraged. We believe our management team has the skills and experience to identify, evaluate and consummate a business combination and is positioned to assist businesses we acquire. However, our management team’s network and investing and operating experience do not guarantee a successful initial business combination. The members of our management team are not required to devote any significant amount of time to our business and are concurrently involved with other businesses. There is no guarantee that our current officers and directors will continue in their respective roles, or in any other role, after our initial business combination, and their expertise may only be of benefit to us until our initial business combination is completed. Past performance by our management team is not a guarantee of success with respect to any business combination we may consummate. --- Our executive offices are located at 174 Nassau Street, Suite 2100, Princeton, New Jersey 08542. Our telephone number is (609) 924-0759.
Our mission is to protect health and well-being through technology. We are a leading technology-driven online insurance distributor in China. We take pride in pioneering the seamless integration of insurance with cutting-edge technologies, and have constructed a highly efficient full consumer service cycle engine. Through this engine, we successfully distribute suitable and high-quality insurance products to over ten million insurance consumers. According to Frost & Sullivan, we were the largest independent insurance distributor in China’s personal life and accident & health (A&H) insurance market in terms of first year premiums in 2023. Our engine enables us to provide customized services for each insurance consumer across personalized recommendation, purchasing, policy management, claim settlements and post-sales services. Built upon a scalable architecture, our engine is equipped with effective predictive capabilities generated from interconnected networks of models. This allows us to continually optimize model outcomes across different media channels, diverse consumer preferences and product depth and breadth. As of December 31, 2024, we had approximately 4,700 models supporting our operations. Our engine offers significant value propositions for insurance consumers and insurance carriers. We act as a unique and efficient gateway to distribute customized insurance products underwritten by our partnered insurance carriers. We have robust collaboration with insurance carriers by empowering them to tailor a variety of flagship insurance products, which in turn enables us to attract and retain a vast consumer base and stimulate their demand for insurance products. By accumulating and analyzing more big data, we gain deeper and wider understanding of consumer demands and behavior. Through all this, we are able to fulfill consumers’ evolving needs and enhance insurance carriers’ sales at the same time. We believe there is substantial untapped market potential for online insurance distribution. According to Frost & Sullivan, the penetration rate of online insurance sales still lags behind the penetration rate of online retail sales. Moreover, the penetration rate of online distribution for personal life and A&H insurance in China, in terms of gross written premium (“GWP”), is anticipated to double over the next five years. Driven by our engine and our market leading position, we are well-positioned to further penetrate this rapidly growing market. --- Our principal executive offices are located at Building 2, No.8 Beichen West Road, Chaoyang District, Beijing, 100101, the People’s Republic of China. Our telephone number at this address is +86 10 64849901. Our main website is https://www.yuanbaobaoxian.cn/. Our registered office in the Cayman Islands is located at the offices of Harneys Fiduciary (Cayman) Limited, 4th Floor, Harbor Place, 103 South Church Street, P.O. Box 10240, Grand Cayman KY1-1002, Cayman Islands. Our agent for service of process in the United States is Cogency Global Inc., located at 122 East 42nd Street, 18th Floor, New York, NY 10168.
We are a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally administered bee venom-based toxin which potentially exhibits diverse therapeutic effects.
We are a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU, and Asia.
Співпраця з надійним європейським брокером - це не тільки можливість отримати доступ до найбільших світових бірж і широкого спектру біржових інструментів, але і можливість брати участь в IPO, поповнивши свій інвестиційний портфель акціями потенційно прибуткових компаній ще до їх первинного розміщення на біржі.
Навіщо приймати участь?
Основні причини, з яких інвестори беруть участь в IPO:
Далеко не всі брокерські компанії пропонують клієнтам таку можливість.
Як придбати акції компанії на IPO?
Щоб взяти участь в публічному розміщенні та інвестувати в акції, достатньо виконати всього 3 прості умови::
1. Стати клієнтом Just2Trade
Для цього достатньо відкрити і поповнити єдиний торговий рахунок MT5 Global. Його можна використовувати не тільки, щоб купити акцій на етапі IPO, але і для інших видів інвестицій::
Крім того, рахунок використовується у в'язці з потужною торговою платформою MetaTrader 5, що має значний ряд переваг, включаючи високу швидкість виконання ордерів і широкі аналітичні можливості.
2. Обрати компанію
Щоб обрати і купити акції компанії на IPO нашим клієнтам було максимально просто, ми публікуємо актуальний календар. Він містить всі найбільш важливі дані про майбутні розміщення:
Також в календарі присутні дані про вже завершені розміщення.
3. Подати заявку
Для того, щоб взяти участь в IPO, досить просто подати заявку на купівлю акцій у особистому кабінеті.
Продати придбані акції можна відразу після першого публічного розміщення їх на біржі або дочекатися закінчення 30-денного lock-up періоду для зниження комісії.